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CRISPR/Cas9 system genome editing is revolutionizing genetics research in a wide 
spectrum of animal models in the genetic era. Among these animals, is the poultry species. 
CRISPR technology is the newest and most advanced gene-editing tool that allows 
researchers to modify and alter gene functions for transcriptional regulation, gene targeting, 
epigenetic modification, gene therapy, and drug delivery in the animal genome. The 
applicability of the CRISPR/Cas9 system in gene editing and modification of genomes in 
the avian species is still emerging. Up to date, substantial progress in using CRISPR/
Cas9 technology has been made in only two poultry species (chicken and quail), with 
chicken taking the lead. There have been major recent advances in the modification of 
the avian genome through their germ cell lineages. In the poultry industry, breeders and 
producers can utilize CRISPR-mediated approaches to enhance the many required genetic 
variations towards the poultry population that are absent in a given poultry flock. Thus, 
CRISPR allows the benefit of accessing genetic characteristics that cannot otherwise 
be used for poultry production. Therefore CRISPR/Cas9 becomes a very powerful and 
robust tool for editing genes that allow for the introduction or regulation of genetic 
information in poultry genomes. However, the CRISPR/Cas9 technology has several 
limitations that need to be addressed to enhance its use in the poultry industry. This review 
evaluates and provides a summary of recent advances in applying CRISPR/Cas9 gene 
editing technology in poultry research and explores its potential use in advancing poultry 
breeding and production with a major focus on chicken and quail. This could aid future 
advancements in the use of CRISPR technology to improve poultry production.
Keywords: CRISPR/Cas9 system, genome editing, transgenic, gene editing, poultry species, primordial germ cells
INTRODUCTION: GENE EDITING TOOLS
The poultry industry is undergoing a gene editing revolution that will change the poultry 
genome in the near future through targeted gene editing of the poultry species (Hwang and 
Han, 2018). The application of genome editing technology in the poultry industry, as well as 
livestock production in general, has improved over the last decade due to the availability of 
precision genome engineering tools (Petersen, 2017; Cooper et  al., 2018). There are three 
commonly used genome-editing techniques for the production of animals, including poultry. 
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The first is the zinc finger nuclease (ZFNs), which is used for 
binding specific DNA domains that complement the target 
DNA sequences. Secondly, transcription activator-Like effector 
nucleases (TALENs) are another gene and genome editing 
technology that employs the nuclease domain to produce double 
strands breaks (DSBs). Finally, yet importantly, the clustered 
regularly interspaced short palindromic repeats (CRISPR)-
associated protein 9 (CRISPR/Cas9), is the most common and 
advanced technique for genome editing. The similarity between 
these three techniques is that they all require the two domains 
for accurate and defectless gene and genome editing. ZFN 
and TALEN differ from CRISPR/Cas9 since both use proteins 
that are fused together as a DNA binding domain while the 
CRISPR/Cas system requires the use of a specific RNA sequence 
molecule for DNA binding instead of the fused proteins (Kim 
and Kim, 2014; Razzaq and Masood, 2018). ZFNs and TALENs 
also require more time to produce an effective system, making 
the two more-time consuming. ZFNs and TALENs have been 
found to have more off target effects as opposed to CRISPR/
Cas9 system (Hwang and Han, 2018; Bahrami et  al., 2020). 
This is because of the availability of computational tools while 
using the CRISPR/Cas9 system that help in designing sgRNAs. 
Therefore, predictability of guide specificity is achieved, and 
this minimizes off-target effects. There is also a chance that 
the design of successful sgRNAs with the available CRISPR/
Cas9 computational tools has a strong on-target activity hence 
reducing off-target effects (Wilson et  al., 2018). The CRISPR/
Cas9 technology uses a specific RNA sequence called guide 
RNA which binds to another target sequence of DNA (target 
DNA) followed by the cleavage of Cas9 where binding has 
occurred. This makes the CRISPR/Cas9 system stand out as 
the most suitable gene editing tool as it improves the frequency 
of precise genome modifications in creating genetically edited 
animals (Chu et  al., 2015). The CRISPR-based system is 
continuously undergoing improvement. The most recent 
development of the CRISPR system employs coexpression of 
CRISPR-associated nucleases 9 and 12a hence having the ability 
to edit multiple target sites in the genome at the same time 
to help study how different genes cooperate in functions (Pennisi, 
2013). Therefore, this system is very important in interrogating 
gene functions (Cong et  al., 2013; Yang et  al., 2013; Najm 
et  al., 2018; Gonatopoulos-Pournatzis et  al., 2020).
CRISPR is a family of DNA sequences found in the genomes 
of prokaryotic organisms such as bacteria and archaea. These 
sequences are derived from DNA fragments of bacteriophages 
that had previously infected the prokaryote. The CRISPR tool 
together with Cas endonuclease is a powerful programmable 
nuclease system (Barrangou et  al., 2007). Studies conducted by 
Jinek et  al. (2012) unveiled a double RNA, known as a guide 
RNA (gRNA) which consisted of a 20-bp CRISPR RNA (crRNA) 
and universal trans-activating crRNA (tracrRNA). This RNA 
coupled with Streptococcus pyogenes type II Cas9 protein can 
induce cleavage of specific target DNA sequences in virtually 
any organism. The Cas9 nuclease activity is initiated by protospacer 
adjacent motif (PAM) sequence NGG, which is usually located 
next to the target site (Anders et  al., 2014). It is possible to 
engineer DNA Cas9-mediated DSBs at a specific genomic locus. 
Non-homologous end-joining (NHEJ) can induce DSB repair 
that disrupts the target gene, generating insertions and deletions. 
Another way of repairing Cas9-mediated DSBs is by homologous 
directed repair (HDR), which allows specific gene editing by 
integrating genetic modifications into the target template (Thomas 
and Capecchi, 1987; Salsman and Dellaire, 2017).
THE STATUS OF CRISPR/Cas9 
TECHNOLOGY IN THE POULTRY 
INDUSTRY
The CRISPR/Cas9 system is among the gene editing technologies 
that are creating a rapid change in poultry genomics for both 
poultry breeding and food production purposes (Doran et  al., 
2017). To date, substantial progress in using CRISPR/Cas9 technology 
has been made in only two poultry species (chicken and quail), 
with chicken taking the lead. The CRISPR technology is not 
aimed at replacing the traditional breeding system, but it provides 
a complementary option by giving the breeder more genetic 
variation to select from since the use of traditional breeding for 
genetic gain has limitations of introducing genetic variation within 
a given population of the poultry flock. The introduction of genetic 
variations using the CRISPR/Cas9 system can be used to improve 
the performance of livestock animals such as poultry.
The CRISPR/Cas9 system has several benefits that could 
be used to improve poultry growth and production performance. 
These benefits include increased bird performance by improving 
the digestibility and overall growth, increased egg production, 
increased bird’s immunity and disease resistance, producing 
birds that are leaner with little or no fat deposition in poultry 
meat for better nutritional profiles. A good example is the 
recent attempt to create chickens that have decreased accretion 
of abdominal fat and increased lean percentage of carcass meat 
by altering the percentage of fatty acid composition (Park et al., 
2019). The CRISPR/Cas9 has also been employed in animal 
welfare improvements through in-ovo sexing (Lee et al., 2019b). 
There is an increased need to produce birds that meet the 
benefits of both commercial producers and consumers in the 
poultry industry. Several strategies have been proposed for the 
generation of transgenic birds to meet several demands in the 
poultry industry. This review discusses various applications of 
the CRISPR/Cas9 technology for genome editing in poultry, 
with a focus on recent and current advances in CRISPR/Cas9-
mediated gene editing technology to produce genetically modified 
birds for various purposes. This review also provides a summary 
and discussion of the challenges, possible approaches, and 
future perspectives on applying CRISPR/Cas9 technology for 
gene and genome engineering in poultry species.
GENERATION OF GENETICALLY 
MODIFIED CRISPR/Cas9-MEDIATED 
BIRDS
CRISPR/Cas9 has gained traction as an efficient method for 
precise gene editing and modification of genomes in various 
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organisms including the avian species (Bai et  al., 2016; 
Oishi et  al., 2016; Wang et  al., 2017b). Various methods have 
been proposed to produce genetically modified animals. In 
mammals, germ-line modification was used in the generation 
of the first transgenic animals such as mice, rabbits, sheep, 
and pigs, by microinjection of the target DNA into the pro-nucleus 
of a fertilized embryo (Gordon et  al., 1980; Hammer et  al., 
1985). Another method that has been used to modify the 
germ line in animals uses embryonic stem cells (ESCs). ESCs 
are genetically modified, then cells are injected into the recipient 
blastocyst to produce germ-line chimeras. Unlike mammals, 
the microinjection of avian ESCs into the zygote in avian 
species is very difficult because the avian zygote is surrounded 
by a large amount of yolk and a small germinal disc. Therefore, 
the first transgenic chicken was produced via retroviral injection 
into the sub-germinal cavity of Eyal-Giladi and Kochav (EGK; 
Eyal-Giladi and Kochav, 1976) stage X embryos (Salter et  al., 
1986). Salter et  al. (1987) created the first retrovirus-mediated 
transgenic chickens by insertion of retroviral genes into the 
chicken germ line. Their transmission frequencies varied from 
1 to 11%. McGrew et  al. (2004) produced germline transgenic 
chickens using lentiviral vectors with transmission efficiencies 
between 4 and 45%. Lillico et  al. (2007) generated the first 
oviduct-specific expression of transgenes in hens but there was 
very low efficiency in the rate at which transgenic birds were 
generated. Various strategies such as the viral infection of stage 
X embryos (Thoraval et  al., 1995; Sherman et  al., 1998), 
microinjection of transgenes into fertilized eggs (Love et  al., 
1994; Sherman et  al., 1998), and embryonic stem cells (Zhu 
et  al., 2005) have been used to produce transgenic birds. In 
van de Lavoir et  al. (2006) generated the first inter-individual 
transfer of chicken primordial germ cells (PGCs). As compared 
to the use of ESCs in mammals, PGCs have been used widely 
in the generation of transgenic birds to overcome the limitation 
of low efficiency germ-line transmission. Transgenes can 
be  introduced into the cultured genomes of PGCs using 
transfection reagents to produce transgenic birds (Han and 
Park, 2018). Transgenic birds have been generated by injection 
of transgenes into the embryonic blood vessel to transfect the 
circulating PGCs to produce germline chimera, although these 
birds had a lower transgenic efficiency (Zhang et  al., 2012; 
Tyack et  al., 2013; Lambeth et  al., 2016). Just before the onset 
of the CRISPR technology, Schusser et  al. (2013) created the 
first knock-out in chickens using efficient homologous 
recombination in primordial germ cells.
With the advent of the CRISPR/Cas9 system, an in vitro 
culture system for PGCs can be  combined with this efficient 
genome-editing system to produce programmable genome-
edited poultry. First, the PGCs in poultry can be  obtained 
from embryonic blood or gonads. The delivery of the CRISPR/
Cas9 system is followed by the establishment of genome-
edited poultry by the microinjection of directly isolated or 
in vitro cultured PGCs into the blood vessels of recipient 
embryos to produce a chimera that hatches and grows into 
mature avian poultry. Oishi et  al. (2016) used the CRISPR/
Cas9 system to efficiently generate ovomucoid gene-targeted 
chickens by transferring transiently drug-selected PGCs into 
recipient embryos using gamma-ray irradiation to deplete 
endogenous PGCs. In one of their most recent works, CRISPR/
Cas9-mediated knock-in of human interferon beta (hIFN-β) 
was created into the chicken exon 2 of the ovalbumin gene 
(Oishi et  al., 2018). Since the generation of the first CRISPR/
Cas9-mediated chicken in 2015 by Veron and his group (Véron 
et  al., 2015) through electroporation of chicken embryos, 
many more studies involving transgenic poultry-related species 
have been published as discussed in the next section. The 
current trend in using the CRISPR/Cas9 system in poultry 
species is incorporating this genome editing tool with genomic 
analysis software such as CRISPR to increase target specificity, 
efficiency, and lower off-target effects. Figure  1 shows a 
workflow using the CRISPR/Cas9 system of programmable 
genome editing in avian species.
CRISPR/Cas9-MEDIATED GENOME 
EDITING IN SELECTED POULTRY 
SPECIES
Many researchers are studying the potential use of CRISPR/
Cas9 for genome editing in the avian species. There is substantial 
progress in using CRISPR/Cas9 technology in chicken and 
quail, with chicken taking the lead as far as the poultry industry 
is concerned. Véron et  al. (2015) published the first CRISPR/
Cas9-mediated chickens 5  years ago. This study coupled the 
use of electroporated chicken embryos with Cas9 and guide 
RNAs encoded plasmids against the transcription factor paired 
box 7 (PAX7). In another recent study, the CRISPR/Cas9 system 
was used to produce chicken using ovalbumin and ovomucoid 
(OVM) genes. In this study, puromycin-selected CRISPR-induced 
mutant-ovomucoid PGCs were transiently transplanted into 
recipient chicken embryos with gamma-ray irradiation (Oishi 
et  al., 2016). Their results indicated that the CRISPR/Cas9 
system was used to induce OVM mutation getting a high 
efficiency (93%) in most donor PGCs with an average mutant 
semen efficiency of 93%. Another study in chicken by Dimitrov 
et  al. (2016) shows a successful germline gene editing by 
efficient CRISPR-mediated homologous recombination in 
primordial germ cells. In this study, an additional loxP site 
was inserted into the variable region segment of a loxP by 
homology directed repair (HDR). This segment had been 
previously inserted into the chicken immunoglobulin heavy 
chain (IgH) locus gene. Their results showed variable germline 
transmission rates (0–90% efficiency) for the different PGC 
lines used.
As studies, PGC lines show different germline competencies 
for genetic modification and gene editing using CRISPR/Cas9 
technology (Naito et  al., 2015). More recently, Cooper et  al. 
(2017) also reported a very successful method of avian genome 
editing known as “sperm transfection-assisted gene editing.” 
This method involves the delivery of CRISPR gRNA and 
Cas9 mRNA mixture directly into a mature chicken sperm 
cell. This method was able to achieve a targeting efficiency 
of 26.6% and about 3% mutation in the green fluorescent 
protein (GFP) and, double sex and mab-3 related transcription 
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factor 1 (DMRT1) genes, respectively. Morin et  al. (2017) 
have recently described a technique that combines the CRISPR/
Cas9 system with in vivo electroporation hence inhibiting 
the gene functions of target genes in the somatic cells of 
developing chicken embryos.
Abu-Bonsrah et  al. (2016) worked on projects that targeted 
genes in the DF-1 and DT-40 cell lines. The genes targeted 
are highly important in embryonic progression for targeted 
genetic manipulation of the chicken genome using the CRISPR/
Cas9 system. These genes included EZH2, CDKN1B, DROSHA, 
MBD3, KIAA1279, HIRA, TYRP1, among others. Many methods 
for CRISPR/Cas9-mediated gene modifications in avian species 
are based on genome modification of PGCs in vitro followed 
by in-ovo injection of modified PGCs into the embryonic blood 
vessels. There is however a possibility of using adenoviral 
vectors for delivery of CRISPR/Cas9 into the bird blastoderm 
in eggs resulting in chimeras that generate offspring having 
targeted mutations (Lee et al., 2019c). This technique of generating 
genome-edited poultry could fast-track many avian research 
studies with potential applications in poultry production. The 
use of poultry-specific CRISPR/Cas9 designed vectors containing 
inserted avian-specific promoters for the expression of guide 
RNA and Cas9 protein can efficiently introduce targeted gene 
modifications in poultry species (Ahn et  al., 2017). This type 
of CRISPR vector can be  applied in many poultry species to 
generate efficient knockout avian cell lines and knockout birds 
for various purposes.
Quail is an important avian species due to its value in 
the poultry food industry and its use as a research model 
for various research areas, especially avian transgenesis and 
genome editing. Currently, the use of CRISPR/Cas9 genome 
editing technology is more widely used in chicken than 
quail since chicken has been the most valuable avian model 
in developmental biology and immunology. Quail is however 
gaining tract as an alternative model to chicken in genome-
editing studies due to their short generation time, high 
level of producing eggs, and small size (Poynter et  al., 2009; 
Lee et  al., 2019c). Ahn et  al. (2017) designed a poultry-
specific CRISPR/Cas9 system that introduces targeted deletion 
mutation in chromosomes of the quail muscle cell lines 
using a customized quail CRISPR vector. In this study, quail 
7SK promoter and CBh promoter were cloned into a CRISPR 
vector for the expression of gRNA and Cas9 protein. The 
gRNA was designed to target the quail melanophilin (MLPH) 
locus. Lee et  al. (2019c) reported CRISPR/Cas9-mediated 
gene knockouts in quail targeting the MLPH gene. In this 
study, CRISPR/Cas9 adenoviral vector was directly injected 
into the quail blastoderm. The offspring obtained from the 
quail chimeras were found to have mutations in the MLPH 
gene. Lee et  al. (2020) targeted the myostatin (MSTN) gene 
to generate mutations in quail in vivo using an adenoviral 
CRISPR/Cas9 system-mediated method. This study showed 
that the mutation in MSTN resulted in the deletion of 
cysteine 42  in the MSTN propeptide region and the 
homozygous mutant quail showed significantly increased 
body weight and muscle mass decreased fat percentage weight 
and increased heart weight as compared to heterozygous 
mutant and wild-type quail.
FIGURE 1 | Genome editing in poultry species. Primordial germ cells (PGCs) in poultry can be obtained from embryonic blood and embryonic gonads. Delivery of 
genome editing tools such as the CRISPR/Cas9 system is followed by the establishment of genome-edited poultry by microinjection of directly isolated or in vitro 
cultured PGCs into the blood vessels of recipient embryos. Avian genome editing systems can be applied to produce various avian models and poultry. This figure is 
reproduced from an earlier publication (Han and Park, 2018, p. 19) after obtaining the permission from Journal of Animal Science and Biotechnology and the 
corresponding author (Jae Yong Han, Seoul National University, Seoul, Korea).
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APPLICATIONS OF CRISPR/Cas9 
SYSTEM IN POULTRY-RELATED 
SPECIES
CRISPR/Cas9-mediated genetically modified poultry-related 
species have many applications in agricultural and biomedical 
research. There is a steady upward trend in the number of 
published reports on the use of CRISPR/Cas9 gene editing 
technology in poultry species since its introduction a few years 
ago. Table 1 contains a selective list of the advances of CRISPR/
Cas9-mediated gene edited poultry species and avian cells. 
This list was selected from recently published reports partly 
because of their significance on various aspects of CRISPR/
Cas9-mediated genome editing in avian species, which is 
described in this review. Figure 2 shows a summary of various 
applications of the CRISPR/Cas9 system in animals many of 
which are yet to be  tested in avian species.
Agricultural Applications of CRISPR/Cas9 
System in Poultry
Various agricultural traits can be achieved using CRISPR/Cas9-
mediated gene editing approaches in poultry. Disease outbreaks 
TABLE 1 | A selective list in advances of CRISPR/Cas9-mediated gene editing in poultry species and avian cells for different purposes.
Genetic Modification in Avian Cells Target gene/Receptor References
CRISPR mediated somatic cell genome engineering in the chicken Paired Box 7 (PAX7) Véron et al., 2015
Site-directed genome knockout in chicken cell line and embryos using CRISPR/Cas 
gene editing technology
C2EIP Zuo et al., 2016
CRISPR/Cas9-mediated genome modification in chicken cell lines (B cell and DT40 
cell lines)
DROSHA, DICER, MBD3, KIAA1279, CDKN1B, 
EZH2, HIRA, TYRP1, STMN2, RET, and DGCR
Abu-Bonsrah et al., 2016
Chicken cell line (DF-1) expressing edited PPAR-γ, OVA, ATP5E using CRISRP/Cas9 
vectors
Peroxisome proliferator-activated receptor-γ 
(PPAR-γ), ATP synthase epsilon subunit (ATP5E), 
and ovalbumin (OVA)
Bai et al., 2016
Chicken DF-1 cells expressing myostatin gene knockout mediated by Cas9-D10A 
nickase without off-target effects
Myostatin Lee et al., 2016
Targeted deletion mutation using poultry-specific CRISPR/Cas9 system in quail 
muscle cell line
Melanophilin (MLPH) locus Ahn et al., 2017
Induced loss-of-function via a frameshift mutation in the CXCR4 gene in chicken 
PGCs
C-X-C chemokine receptor type 4 (CXCR4) Lee et al., 2017c
CRISPR/Cas9-mediated chicken Stra8 gene knockout in male germ cell 
differentiation
Stimulated by retinoic acid 8 (Stra8) gene Zhang et al., 2017
CRISPR/Cas9-mediated genome modulation of cis-regulatory interactions and gene 
expression in the chicken embryo
Msx1, Pax7, Sox9, c-Myb and Ets1 Williams et al., 2018
Chicken DF-1 cells expressing eGFP under control of the chicken GAPDH promoter Glyceraldehyde-3-Phosphate Dehydrogenase 
(GAPDH) gene
Antonova et al., 2018
Genetic resistance to Avian Leukosis Viruses induced by CRISPR/Cas9 editing of 
specific receptor genes in chicken DF-1 cells
tva, tvc, and tvj receptor genes Koslová et al., 2018
CRISPR/Cas9-Mediated TBK1 gene knockout chicken DF-1 cells TANK binding kinase 1 (TBK1) Cheng et al., 2019
HMEJ-mediated efficient site-specific gene integration in chicken DF-1 cells Deleted in AZoospermia-Like (DAZL) gene Xie et al., 2019
Direct delivery of adenoviral CRISPR/Cas9 vector into the blastoderm for generation 
of targeted gene knockout in quail
Melanophilin (MLPH) gene Lee et al., 2019c
Sequential disruption of ALV host receptor genes in chicken DF-1 cells tva, tvb, and chicken Na+/H+ exchange 1 (chNHE1) 
genes
Lee et al., 2019a
Functional study of the ANP32A genes mediated by the CRISPR/Cas9 system in 
chicken cell lines
Acidic (Leucine-Rich) Nuclear Phosphoprotein 32 
Family, Member A (ANP32A)
Park et al., 2020
Genetic Modification in Poultry Species
Chicken expressing CRISPR/Cas9-mediated OVA and OVM mutations Ovalbumin (OVA) and ovomucoid (OVM) Oishi et al., 2016
Chicken expressing CRISPR-targeted locus in PGCs Immunoglobulin heavy chain locus of EGFP gene Dimitrov et al., 2016
Chick embryo optimized for early loss-of-function using CRISPR/Cas9 Pax7 and Sox10 Gandhi et al., 2017
Chicken Embryo expressing CRISPR/Cas9 Somatic cells genes Morin et al., 2017
Induced loss-of-function via a frameshift mutation in the CXCR4 gene in chicken 
PGCs
C-X-C chemokine receptor type 4 (CXCR4) Lee et al., 2017c
Chickens overexpressing human IFN-β Ovalbumin (OVA) Oishi et al., 2018
Chicken primordial germ cells expressing gene insertion into Z chromosome for avian 
sexing model development
Z chromosome Lee et al., 2019b
Efficient knock-in at the chicken ovalbumin locus using adenovirus as a CRISPR/
Cas9 delivery system
Ovalbumin (OVA) Qin et al., 2019
Precise CRISPR/Cas9 editing of the NHE1 gene renders chickens resistant to the J 
subgroup of avian leukosis virus
NHE1 gene Koslová et al., 2020
Single amino acid deletion in myostatin propeptide of Japanese quail using CRISPR/
Cas9
Myostatin (MSTN) gene Lee et al., 2020
Acquiring resistance against a retroviral infection via CRISPR/Cas9 targeted genome 
editing in a commercial chicken line
Chicken Na+/H+ exchanger type 1 (chNHE1) 
receptor
Hellmich et al., 2020
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FIGURE 2 | A summary of various applications of the CRISPR/Cas9 system in animals many of which are yet to be tested in poultry species.
in poultry pose a significant risk to the commercial poultry 
industry causing an increased cost of production for commercial 
poultry producers. There is a high demand for genetically 
modified chickens that are highly resistant to a specific disease-
causing microorganism, and the available genome editing tools 
could help in this endeavor (Sid and Schusser, 2018). Avian 
influenza virus (AIV) is a poultry disease with high 
hypervirulence that causes sporadic pandemic events that lead 
to a high mortality rate (Suarez, 2000). Most vaccination 
strategies to control AIV are ineffective hence the need to 
breed resistance to AIV (Doran et  al., 2017). There have been 
several recent attempts to suppress the transmission of AIV 
in genetically modified chickens. Lyall and his group generated 
transgenic chickens expressing a short-hairpin RNA (shRNA) 
that targets the viral genome. The shRNA is designed to inhibit 
and block influenza virus polymerase hence interfering with 
virus propagation, (Lyall et  al., 2011).
Recent findings on the species-specific host co-factor 
polymerase activity of avian influenza viruses in chickens show 
that adding approximately 33 amino acid inserts in the chicken 
acidic nuclear phosphoprotein 32 family member A (chANP32A) 
protein enhances avian polymerase activity in avian cells. 
CRISPR/cas9 can also be  used to substitute the chANP32A 
gene with huANP32A that has enhanced avian polymerase 
activity in avian cells. This could impair the enhanced polymerase 
activity of the avian influenza virus in chicken cells, thereby 
providing resistance to poultry species against influenza (Long 
et  al., 2016). More recently, Park et  al. (2020) conducted a 
study targeting chicken ANP32A using CRISPR/Cas9-mediated 
genome editing to examine the functional roles of ANP32A 
and other members of the ANP32 family using avian cell 
lines. The absence of the retinoic acid-induced gene I  (RIG-I) 
in avian species has been shown to increase the susceptibility 
of chickens against AIV infection as compared to ducks where 
it is present hence making the ducks more resistant to influenza 
viruses (Barber et  al., 2010). CRISPR/Cas9 can be  used to 
introduce RIG-I-like disease-resistant genes in the genomes of 
poultry related species then breed these birds having higher 
resistance to AIV (Smith et  al., 2015; Blyth et  al., 2016). More 
recent studies conducted by Byun et al. (2017) have established 
the possibility to suppress AIV transmission in genetically 
modified birds that express the 3D8 single chain variable 
fragment (scFv).
Another poultry disease that causes economic losses in the 
poultry industry is the avian leukosis virus (ALV). ALV is a 
retrovirus that causes tumors in avian species by inserting a 
copy of their genome DNA into the host cell. Kučerová et  al. 
(2013) identified W38 as the critical amino-acid residue in 
chicken Na+/H+ exchange 1 receptor (NHE1), whose deletion 
might confer the resistance to subgroup J avian leukosis virus. 
Lee et  al. (2017a) were able to induce acquired resistance to 
ALV-J infection by using the CRISPR/Cas9-mediated homologous 
recombination in cultured chicken DF-1 cells. Lee et al. (2017c) 
modified critical residues of chicken NHE1  in cultured cells 
to induce resistance to viral infection and create mutations of 
the tryptophan residue at position 38 (Trp38) using single-
stranded oligodeoxynucleotide (ssODN) recombination to confer 
resistance to ALV-J. In another research by Koslová et  al. 
(2018), genetic resistance to ALV was successfully induced 
using the CRISPR/Cas9-mediated approach. Some frame-shifting 
mutations were introduced into tva, tvc, and tvj loci encoding 
receptors for the A, C, and J ALV subgroups, respectively. 
Therefore both Lee et  al. (2017a) and Koslová et  al. (2018) 
successfully produced KO or gene edits of NHE1 in the chicken 
DF-1 cell line. Lee et  al. (2019a) used a CRISPR/Cas9-based 
disruption strategy of exon 2 within the tumor virus locus A 
gene (tva) of DF-1 fibroblasts to confer resistance to infection 
by ALV subgroup A. More recently, Koslová et  al. (2020) 
prepared CRISPR/Cas9-mediated gene-edited chickens and found 
out that gene editing of the NHE1 gene renders chickens’ 
resistance to the J subgroup of avian leukosis virus. Therefore, 
Koslová et  al. (2020) were able to produce an ALV-J-resistant 
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chicken line as the first example of true site-specific gene 
editing. Hellmich et  al. (2020) corroborated this strategy in 
commercial chicken lines by precise deletion of chicken NHE1 
W38 using CRISPR/Cas9-system in combination with homology 
directed repair to induce ALV-J resistance. These examples 
show that CRISPR/Cas9 genome editing technology can be used 
widely to modify poultry species to produce a line of birds 
that exhibit desired resistance characteristics to viral infection. 
This might be  the initial step in developing a virus-resistant 
line of birds in poultry. The use of such CRISPR-mediated 
genome edited poultry could substantially reduce a lot of 
economic losses as well as decreasing the cost of production 
in the poultry industry.
Increasing the performance of birds by enhancing muscle 
growth is another important agricultural application of CRISPR/
Cas9-mediated gene editing in poultry species. MSTN suppresses 
skeletal muscle development and growth in animals (McPherron 
et al., 1997). A mutation in myostatin has resulted in increased 
muscle mass in mammals and fishes. In poultry, the increasing 
growth performance of birds can be  enhanced by targeting 
MSTN to suppress its inhibitory effects on muscle growth. 
For example, a non-frameshift mutation in the MSTN of 
Japanese quail resulted in a significant increase in body weight 
and muscle mass (Lee et  al., 2020). A disruption or removal 
of MSTN by genetic mutations using CRISPR/Cas9 inhibits 
its anti-myogenic function resulting in increased muscle mass 
in MSTN knockdown chickens (Bhattacharya et al., 2019). This 
is an important agricultural application in the poultry industry 
that could enhance bird performance and increase productivity, 
and help solve food shortage problems.
Applications of CRISPR/Cas9 in 
Biomedical Research
Genome editing is a major development in biomedical research, 
with the current trend of innovative approaches providing 
directions for the treatment of various genetic and non-genetic 
diseases in the future. The availability of the CRISPR/Cas9-
mediated gene and genome editing system has enabled the 
advent and use of more efficient strategies in gene targeting 
and the creation of gene edited avian species. This has guided 
recent and on-going advancements in biomedical research in 
the animal biotechnology field.
CRISPR/Cas9 technology has ushered in an innovative era 
in genome editing technology for the manipulation of invaluable 
avian models such as chickens. By applying CRISPR/Cas9 
gene editing technology, researchers will be  able to create 
an efficient bioreactor system for producing valuable proteins 
in poultry species. In chickens, the bioreactor system will 
enable efficient production and easy purification of egg white 
protein in large amounts (Lillico et al., 2005). The development 
of chickens as bioreactors for the production of target proteins 
has mostly utilized ovalbumin promoters (Park et  al., 2015). 
The development of transgenic hens for protein production 
in eggs is highly necessary for the expression of therapeutic 
proteins which has resulted in significant advances in the 
generation of transgenic chicken models in this advancing 
era of genome editing. Oishi and colleagues have shown 
recently that the human interferon beta (hIFN-β) can 
be  integrated into the chicken ovalbumin locus used in the 
production of hIFN-β in egg white (Oishi et  al., 2018). Oishi 
et  al. (2016) used CRISPR/Cas9 technology to demonstrate 
that disruptions of ovalbumin and ovomucoid genes had the 
potential to produce low allergenicity in eggs, which allowed 
a reduced immune response in egg white sensitive individuals. 
Therefore CRISPR/Cas9-mediated genome editing is expected 
to be  key in the mitigation of allergic reactions caused by 
chicken eggs in some individuals by ensuring that chicken 
meat and eggs are allergen-free. This can be  achieved by 
knocking out allergen-related genes such as ovalbumin and 
ovomucoid. This type of progress is important in the production 
of safe food products as well as the production of vaccines 
in the pharmaceutical industry.
The production of therapeutic antibodies against antigens 
is now possible through humanized chicken for therapeutic 
applications. The loxP site was inserted into the variable region 
of the immunoglobulin heavy chain using the CRISPR/Cas9-
mediated approach (Dimitrov et al., 2016). Production of these 
genome-edited chickens will provide numerous opportunities 
for the discovery of therapeutic antibodies: a game-changer 
in biomedical research.
LIMITATIONS OF USING CRISPR/Cas9 
SYSTEM IN POULTRY PRODUCTION
Despite the many advantages and breakthroughs that CRISPR/
Cas9 system offers the poultry industry, several concerns touch 
on the ethical, legal, and social issues that affect the use of 
this powerful genome editing tool. One big concern of using 
the CRISPR/Cas9 technology is that this system generates 
off-target effects that can be  very harmful. Off-target effects 
could play a critical role in the recognition and destruction 
of hypervariable viral nucleic acids or the plasmid DNA of 
beneficial bacteria that can potentially alter the microbiome 
profiles of a bird. With the newly developed ways of delivering 
the DNA-editing tool CRISPR-Cas9 into microorganisms, there 
is a possibility of altering the birds’ microbiome composition 
just like in other organisms (Hamilton et al., 2019; Ramachandran 
and Bikard, 2019). The cutting frequency determination (CFD) 
score of up to 0.28 has been found in some cases (Oishi 
et  al., 2016; Koslová et  al., 2020). The CFD score range from 
0 to 1, with a higher off-target score, has much off-target 
potential that should be  avoided. Off-target effects create 
unfavorable mutations at random sites that impact the precision 
of genome modification which raises concerns about safety 
and efficacy especially when the birds are raised for meat and 
egg production (Zhang et  al., 2015; Chira et  al., 2017).
There are high chances of having targeted alleles carrying 
additional modified and integrated targeted vectors through deletions 
and duplications because the DNA repair system has a scope 
that cannot integrate DNA fragments in the genetic makeup of 
an organism. This is based on the fact that the molecular mechanism 
that is used in the insertion of DNA fragments is highly mediated 
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by the DNA repair mechanism that is turned on by the DSB 
created by the Cas9 enzyme (Li et  al., 2015).
Decreasing the off-target effects may cause an upward trend 
in future applications of CRISPR/Cas9 gene-editing technology, 
especially in the generation of food animals such as poultry 
(Kleinstiver et  al., 2016; Lee et  al., 2017b). This goal could 
be achieved through studies that develop understanding of off-target 
mechanisms. The advent of transcriptome sequencing technology 
and the availability of high-throughput sequencing technology 
screening of gene edited animals can be  enhanced to provide 
critical information about the potential off-targets associated with 
the use of CRISPR/Cas9 system in food animals (Roy et al., 2018).
Another major disadvantage of using the CRISPR/Cas9 
system in poultry production is the low transfection efficiency 
(<2%) of avian cells in genome editing (Tyack et  al., 2013; 
Lambeth et  al., 2016) and the low germ-line transmission 
efficiency of less than 10% (Cooper et  al., 2017; Hwang and 
Han, 2018). Just like other genome editing tools (TALENs 
and ZFNs), CRISPR/Cas9 system needs much more 
improvement to increase transfection efficiency and germ-line 
transmission. In the years before the advent of CRISPR 
technology, there were attempts to generate transgenic chickens 
but the germ-line transmission rate from one generation to 
another was very low. In Mozdziak et  al. (2003) research 
group reported the first credible study of a genetically modified 
line of chickens that express a protein ubiquitously (Mozdziak 
et  al., 2003). In Mozdziak et  al. (2006) and his colleagues 
evaluated germline transmission rates of PGCs using 
fluorescence-activated cell sorting (Mozdziak et  al., 2006). 
Many studies discussed earlier involving in ovo electroporation 
of chicken embryo proved to be  very inefficient for germline 
transmission. There is a high possibility that the issue of low 
germline transmission efficiency in the production of genetically 
modified birds can be  improved through PGC-mediated 
transgenesis and genome editing. First, PGCs are transfected 
then followed by subsequent injection into a host animal. 
The germline transmission rates obtained here are quite 
acceptable though they are variable from 0–90%. This could 
be an alternative strategy for improving germline transmission 
efficiency (Dimitrov et  al., 2016).
Trends in the current meat market show that there are 
difficulties in the commercialization of transgenic poultry products 
generated by CRISPR/Cas9 technology in various countries around 
the world. This is mainly because of the high cost of developing 
this system and the major constraints of regulatory agents on 
genetically modified organisms (Manghwar et  al., 2019).
CURRENT STRATEGIES FOR 




The most broadly utilized Cas9 is the Streptococcus pyogenes 
Cas9 (SpCas9), but it has been found to generate genome-wide 
off-target mutations. In the last 5  years, scientists have been 
working to develop Cas9 variants and other Cas9 orthologous 
that show minimized off-target effects and increased specificity 
to solve this issue. Among these, the available Cas9 variants 
include SaCas9, SpCas9-Nickase, dCas9, dCas9-FokI, xCas9, 
Cas9-NG, evoCas9, SpCas9-HFI, eSpCas9, Hypa-Cas9, Sniper-Cas9, 
HiFi Cas9, SpG, and PAM-less SpRY.
SaCas9 is a nuclease derived from Streptococcus aureus. It 
is widely used for ex  vivo or in vivo gene therapy instead of 
SpCas9 due to its small size, which allows packaging in adeno-
associated-virus (AAV) vectors. The saCas9 also recognizes a 
longer PAM sequence (5'-NNGRRT-3') as opposed to the shorter 
5'-NGG-3' sequence recognized by SpCas9. Using SaCas9 for 
genome editing may therefore have very minimal off-target 
mutations (Kumar et  al., 2018). Genome-wide unbiased 
identification of DSBs enabled by sequencing (GUIDE-seq) 
performed to detect off-targets show that the on-target activity 
was higher in the saCas9 than the wild type SpCas9 (Ono 
et  al., 2019). SpCas9 nickase which is engineered through 
deactivation of the RuvC domain of SpCas9 through mutation 
has shown to have reduced off-target effects by more than 
1,500 folds when compared with the wild type SpCas9 (Frock 
et  al., 2015). dCas9-FokI which is deactivated or simply dead 
SpCas9 fused with the catalytic domain of FokI has shown 
decreased off-target sites and increased on-target activity by 
140-fold when compared with the wild type SpCas9 (Wyvekens 
et  al., 2015). XCas9, Cas9-NG, and evoCas9 is another set of 
engineered variants of spCas9 that have shown minimized 
off-target effects minimized and increased specificity in both 
animals and plants. The variant xCas9 recognizes a broad range 
of PAMs including GAT, GAA, and NG. Therefore, compared 
to SpCas9, xCas9 has a higher specificity and low off-target 
effects in animal cells (Liang et  al., 2015; Hu et  al., 2018). 
The GUIDE-seq has been used to assess the efficiency of 
Cas9-NG and evoCas9 at different loci. The on-target activity 
was significantly higher than off-target activity in both Cas9-NG 
(Nishimasu et  al., 2018) and evoCas9 (Kleinstiver et  al., 2015) 
than the wild type SpCas9. Other SpCas9 variants such as 
SpCas9-HFI (Kleinstiver et  al., 2016), eSpCas9 (Slaymaker 
et  al., 2016), Hypa-Cas9 (Chen et  al., 2017), Sniper-Cas9 (Lee 
et  al., 2018), HiFi Cas9 (Vakulskas et  al., 2018), SpG and 
PAM-less SpRY (Walton et  al., 2020) have been used more 
recently to minimize genome-wide off-target effects with 
exceptional accuracy.
Improved Viral and Non-Viral CRISPR 
Delivery Methods
Viral vector delivery systems have been extensively used to 
deliver the components of gene-editing in gene therapy. In the 
CRISPR/Cas9 gene-editing system that uses viral based delivery 
methods, the Cas9 and gRNA are packaged into plasmid DNA, 
which is delivered via the viral vector to the target cell. This 
delivery increases the chances of off-target effects since the 
CRISPR/Cas9 components exist persistently in the target cell 
resulting in elevated Cas9 levels. Adeno viruses (AdV) have 
been used in viral vector delivery systems to minimize off-target 
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effects since AdV show very minimal potential to integrate 
into the target cell genome (Gaj et al., 2017; Lino et  al., 2018).
The non-viral delivery system involves directly delivering a 
ribonucleoprotein (RNP), which consists of the Cas9 protein 
in complex with a targeting gRNA to the target cells. The 
main advantage of this method is that RNPs may limit the 
potential for off-target effects since the Cas9-gRNA RNP is 
degraded over time (Vakulskas and Behlke, 2019). Minimized 
off-target mutations are possible when RNP complexes are 
delivered by liposome-mediated transfection as opposed to 
plasmid DNA transfection (Liang et  al., 2015).
Base Editing
NHEJ can introduce DSBs at unintended positions to the 
target gene hence generating insertions and deletions that 
are off targets. This causes off-target effects. Recently, a new 
genome-editing technique has been developed for base editing. 
This technique can change specific nucleotides in the genome 
without the introduction of double-stranded (ds) DNA breaks 
(Komor et  al., 2016, 2018; Naeem et  al., 2020). Base editing 
technique comprises of dCas9, catalytic base modification 
enzyme (deaminase), and sgRNA. The two categories of base 
editors developed recently are Cytosine base editors (CBE) 
and Thymine base editors (TBE) which can change C/G to 
T/A and A/T to G/C, analogously. The use of base editing 
has enabled new capabilities and applications in the genome 
editing world despite its recent introduction because it shows 
significant gene editing efficiency (Rees and Liu, 2018). An 
efficient base editing delivery system enhances the reduction 
of off-target mutations (Zhou et  al., 2019).
Prime Editing
Recently, Anzalone et al. (2019) reported that the development 
of a novel genome editing experimental approach that mediates 
all possible base-to-base conversions, “indels,” and combinations 
in mammalian cells without the need of a double-strand break 
or donor DNA (dDNA) templates. This new gene-editing method 
is called prime editing. Transition mutations by base editing 
are limited to installing four transition mutations efficiently, 
that is, C to T or G to A, A to G, and T to C. This strategy 
can therefore only make four of the 12 possible base pair 
changes. However, Prime editing can install all 12 possible 
transition changes (C/A, C/G, G/C, G/T, A/C, A/T, T/A, and 
T/G) in the genome. The prime editing system offers a new 
approach to minimizing off-target effects and increasing target 
specificity in genomes but requires more research on animal 
models to move it into therapeutic gene editing or for human 
consumption (Anzalone et  al., 2019).
Anti-CRISPR Proteins
The recent discovery of the protein inhibitors of CRISPR/
Cas systems, called anti-CRISPR (Acr) proteins, has enabled 
the development of more efficient, controllable, and precise 
CRISPR/Cas tools in animal cells (Marino et  al., 2020). More 
than 50 anti-CRISPR proteins have now been characterized 
up to date, each with its own means of blocking the 
cut-and-paste action of CRISPR systems (Dolgin, 2020). AcrIIA2 
and AcrIIA4 proteins have been found to inhibit the CRISPR/
Cas system and are hence desired to decrease off-target 
modifications without decreasing on-target activities in cells 
(Shin et  al., 2017; Basgall et  al., 2018).
FUTURE PERSPECTIVES
CRISPR/Cas9 technology has increased significantly the efficiency 
of the gene editing process when compared to the other modern 
existing processes of homolog recombination. CRISPR/Cas9-
mediated gene editing is more advanced in small mammals 
such as mice and big mammals such as pigs than in avian 
species such as chickens, but very soon gene editing in poultry 
will enter into a highly competitive era of genome editing. In 
the future, the generation of poultry species expressing Cas9 
will be  beneficial to the study of biological processes. Studies 
of biological processes that enable us to understand the functions 
of the genes that may be  involved in growth will be  faster 
and easier in the future. This is already being done in pigs 
(Wang et al., 2017a) and can be utilized in poultry. In addition, 
the use of CRISPR/Cas9 to target PGCs offers a promising 
method of generating genetically engineered avian species with 
any desired gene characteristics (Abu-Bonsrah et  al., 2016).
We predict that the future of the poultry meat industry 
will involve the production of birds that are highly efficient 
in feed utilization and lean meat which make them even more 
attractive for human consumption. Although the possibility of 
decreasing feed to gain ratio in poultry may be  very minimal, 
this could change with the production of CRISPR-mediated 
transgenic chickens. There has been tremendous progress in 
the production of other meat animals such as pigs, with 
decreased fat deposition using the CRISPR/Cas9 system. For 
example, Zheng and his research group in China reconstructed 
the uncoupling protein 1 (UCP1) gene using CRISPR/Cas9 
technology in the white adipose tissue of swine species, hence 
decreasing the accretion of fat (Zheng et  al., 2017). In their 
study, Zheng and colleagues efficiently inserted a mouse 
adiponectin-UCP1 into the porcine endogenous UCP1 locus. 
The UCP1 knock-in pigs that were generated showed a decreased 
deposition of fat and increased carcass lean percentage. In 
poultry, the use of the CRISPR/Cas9 system has only recently 
taken off and is currently being used in targeting candidate 
avian genes in poultry species to produce birds that have higher 
lean meat and less fat which may lead to increased consumption 
by consumers (Park et  al., 2019).
The production of foreign proteins in eggs can be  utilized 
for industrial and therapeutic applications. Novel methods 
such as site-directed integration have been used by 
biotechnology companies such as AviGenics Incorporated 
(Athens, Georgia) and Crystal Bioscience Incorporated 
(Emeryville, California) to successfully create transgenic poultry 
for use in the production of biopharmaceutical proteins. Newer 
and innovative technologies such as CRISPR/Cas9 can further 
improve the efficiency of the production of these proteins. 
With the availability of CRISPR/Cas9 technology, cell and 
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animal transgenesis providing a more efficient strategy through 
gene targeting and the creation of transgenic birds that will 
lead to advancements in biomedical research applications. 
Antibody-producing companies can purify overexpressed human 
antibodies from the eggs of poultry species such as chicken 
and quail to produce recombinant proteins and vaccines using 
CRISPR/Cas9-mediated approaches (Farzaneh et  al., 2017). 
Furthermore, the production of antibodies using poultry eggs 
by utilizing the CRISPR/Cas9 system represents an economical 
and stress-free method of producing specific antibodies for 
therapeutic applications (Amro et  al., 2018).
A great deal of time and resources are required before 
the CRISPR-Cas9 system becomes 100% safe and effective 
in the generation of food animals. If the remaining safety 
and efficiency concerns are fully addressed, then the CRISPR/
Cas9 system could be effectively used to improve food quality 
and production. Diversity among the poultry species should 
be  strongly encouraged and pursued using gene editing 
technologies. However, because the resulting birds will 
be  genetically engineered and modified, the Food and Drug 
Administration (FDA) will have to review and approve the 
use of such poultry birds after guaranteeing that the meat 
and eggs produced are safe for human consumption. It is 
expected that in the near future, CRISPR/Cas9-mediated 
genome editing research will extend to other categories of 
poultry species such as turkeys, geese, ducks, and guinea 
fowl across the world since major progress has been made 
in chicken and quail.
Several recent trends might fast-track the generation of 
transgenic birds in the near future. First, in vitro genetically 
manipulated PGCs could be  re-introduced not only into 
the embryonic blood but also into the testes of sterilized 
adult recipients. After such transplantation, donor PGCs 
colonize the spermatogenic epithelium and mature into 
fertile sperm. This method was recently described by Trefil 
et  al. (2017). Compared with existing approaches, this 
procedure will become the method of choice in the future 
because it is more efficient, faster, requires fewer animals, 
and could broaden PGC technology in other poultry species. 
Secondly, genetic sterility might be  a very useful tool for 
CRISPR/Cas9-assisted gene editing. Genetically sterile 
chickens can be  used as surrogate hosts for germ line 
transfer (Woodcock et  al., 2019) or, in the future, for 
efficient transgenesis. Finally, the use of adenoviral vectors 
for CRISPR/Cas9 delivery could bring the technique of 
virus subgerminal injection back into routine use (Lee et al., 
2019c). The implementation of this method could accelerate 
avian knockout studies and lead to the advancement of 
future agricultural applications.
CONCLUDING REMARKS
The development and improvement of CRISPR technology over 
the years has enabled access to generate transgenic lines of 
birds for meat or egg production, mainly for food. The impact 
of CRISPR technology could potentially lead to the efficient 
improvement and sustainability of poultry products, which will 
help address challenges associated with universal food security. 
Birds raised for meat and egg production using the CRISPR 
technology could have an immense impact on the advancement 
of poultry related traits such as feed conversion, digestibility, 
increased egg production, growth, and overall improved 
performance of birds. Innovations resulting from CRISPR 
technology could also lead to developments in fields such as 
disease resistance, immune function, and vaccine delivery. This 
will in turn enhance poultry health, increase the safety of 
vaccines produced using chicken eggs, and increase food safety 
and production.
The future applications of CRISPR technology in poultry 
have promising and tremendous potentials in biomedical research 
that could benefit humankind due to vast opportunities for 
disease treatment and prevention. Most of these applications 
have been focused on chickens that show great potential for 
biomedical research. Finally, yet importantly, the latest 
progressions in CRISPR/Cas9 gene editing technologies might 
assist in scaling down or abolishing barriers such as the 
difficulties of gaining regulatory approval and the public 
perception and acceptability of CRISPR technology in the 
production of food animals.
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